The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Older Adults: a Feasibility Study
Launched by NKS OLAVIKEN GERONTOPSYCHIATRIC HOSPITAL · Jan 15, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Emotional disorders such as anxiety and depression are the most common mental health problems affecting older people, and are highly comorbid . The prevalence is high (greater than 25 %), with increasing prevalence for people with comorbid somatic disorders (greater than 40%). Evidence suggests that psychological treatment for older adults is as effective as for working-age adults and maybe even more effective in old adults with comorbid somatic disorders. Despite this, older adults are generally under-represented in psychological services.
Most older adults with emotional disorders receiv...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinically significant symptoms of anxiety or depression based on self-report and clinical interview
- • Score on the MMSE-NR above 26 and competent to give informed consent as evaluated by a structural clinical assessment
- • Stable use of psychotropic medication for the last month. Periodic use of z-hypnotics is not exclusion criteria but will be restricted to a limited and pre-planned dosage per week. Stabilization of psychotropic medication can be offered to eligible patients before participation.
- • Prepared to share their challenges and work on maladaptive emotion regulation strategies in a group setting.
- • Able to attend most sessions.
- Exclusion Criteria:
- • Conditions requiring specialized treatment such as active psychosis and/or mania, untreated or unstable bipolar disorder, psychosis spectrum disorders or severe depressive episode
- • Acutely increased risk of suicide or deliberate self-harm
- • Dementia or amnestic mild cognitive impairment
- • Substance abuse including psychoactive drugs
- • Habitual use of prescribed anxiolytics or opiods. Help with gradual reduction and elimination before inclusion in treatment will be offered to potential participants
- • Uncorrected hearing loss
- • Symptoms of personality disorders that hinder participation in the group
- • Simultaneously participating in other psychotherapy
- • Living with ongoing highly social burden where greater flexibility in treatment is needed
About Nks Olaviken Gerontopsychiatric Hospital
NKS Olaviken Gerontopsychiatric Hospital is a specialized healthcare institution dedicated to providing comprehensive care and innovative treatment for elderly patients with psychiatric conditions. With a focus on gerontopsychiatry, the hospital integrates clinical research and evidence-based practices to enhance mental health outcomes for seniors. Committed to advancing the field, NKS Olaviken actively sponsors clinical trials aimed at exploring new therapeutic interventions and improving the quality of life for its patients. The hospital's multidisciplinary team of experts collaborates closely with academic and research institutions to foster advancements in geriatric mental health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, Vestland, Norway
Patients applied
Trial Officials
Kristine G Madsø, Clinical Psychology (PhD)
Principal Investigator
NKS Olaviken Gerontopsychiatric Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported